Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 3:34 AM ET

Professional Services

Company Overview of H. Lee Moffitt Cancer Center & Research Institute

Company Overview

H. Lee Moffitt Cancer Center & Research Institute is a not for-profit institution that focuses on prevention and cure of cancer. The institution offers private patient rooms, blood and marrow transplant programs, outpatient treatment programs, patient care, research, and education services. Additionally, it publishes Today's Tomorrows, a community newsletter about cancer care, research, and education. H. Lee Moffitt was founded in 1986 and is based in Tampa, Florida.

10441 University Center Drive

Tampa, FL 33612

United States

Founded in 1986

Phone:

888-663-3488

Key Executives for H. Lee Moffitt Cancer Center & Research Institute

Chief Executive Officer and Center Director
Age: 64
Executive Vice President Applied Science
Vice President of Public Relations and Marketing
Compensation as of Fiscal Year 2014.

H. Lee Moffitt Cancer Center & Research Institute Key Developments

Cancer Genetics, Inc. Enters into Multi-Year Research Collaboration with Moffitt Cancer Center for Genomics-Based Prediction of Side Effects Associated with Chemotherapy

Cancer Genetics, Inc. announced that it has entered into a series of collaborative studies with leading researchers at Moffitt Cancer Center in Tampa, Florida. The studies, led by Moffitt researchers Heather Jim, PhD, Diane Portman, MD, Howard McLeod, PharmD, and Gillian Bell, PharmD will examine a number of genetic variants as predictors for the most common side effects associated with chemotherapy treatment. Chemotherapy-induced nausea and vomiting (CINV) is a significant clinical challenge experienced by over 50% of patients receiving chemotherapy, even when general-purpose prophylactic anti-emetic therapies are prescribed according to clinical guidelines. The first of these collaborative studies will seek to validate and improve existing risk prediction indices of acute and delayed CINV in patients undergoing chemotherapy. This prospective study will determine whether the inclusion of variations in genes involved in the metabolism of anti-emetic drugs improves the ability to accurately predict which patients are more likely to experience side effects from chemotherapy regimens. Tailored anti-emetic treatment in patients at risk of CINV has the potential to significantly reduce incidence, while decreasing CINV-related medical visit costs, which average $40,001 per patient. A second collaboration will examine the role of individual genetic variants in the effectiveness of pain control in cancer. Pain is one of the most difficult symptoms associated with cancer and its treatment. Opioid and non-opioid analgesics and co-analgesics are frequently used to improve pain control, but patients vary considerably in their response to these drugs. This study will include Moffitt cancer patients treated in the outpatient setting and will seek to identify genetic associations for patient-reported pain outcomes.

H. Lee Moffitt Cancer Center Names Mariana Bugallo-Muros as Chief Human Resources Officer

H. Lee Moffitt Cancer Center named a new Lead Executive for the Human Resources Department. Mariana Bugallo-Muros will be Chief Human Resources Officer for the Tampa-based center, filling the role left vacant by Joanne Olson, who retired in March. Bugallo-Muros, who is expected to start at Moffitt in June, previously was vice president for Partners HealthCare in Boston.

Moffitt Cancer Center Names Jennifer Greenman to Vice President and Chief Information Officer

Jennifer Greenman has been named Vice President and Chief Information Officer at Moffitt Cancer Center. She will report to Mark Hulse, R.N., Moffitt's Chief Administration Officer. In her new role, Greenman will provide leadership and strategic direction for technology initiatives that support Moffitt's mission to contribute to the prevention and cure of cancer. Greenman has been with Moffitt since July 2013. She previously served as the cancer center's Senior Director for Application Services.

Similar Private Companies By Industry

Company Name Region
Scribner Fowlke United States
Eagle Enterprises United States
PropTester Inc. United States
Slade- MacE & Co. United States
Allis Information Management, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact H. Lee Moffitt Cancer Center & Research Institute, please visit www.moffitt.usf.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.